Cargando…

Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration

BACKGROUND: High density lipoprotein (HDL) has been proved to be a protective factor for coronary heart disease. Notably, HDL in atherosclerotic plaques can be nitrated (NO(2)-oxHDL) and chlorinated (Cl-oxHDL) by myeloperoxidase (MPO), likely compromising its cardiovascular protective effects. METHO...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Boda, Zu, Lingyun, Chen, Yong, Zheng, Xilong, Wang, Yuhui, Pan, Bing, Dong, Min, Zhou, Enchen, Zhao, Mingming, Zhang, Youyi, Zheng, Lemin, Gao, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223295/
https://www.ncbi.nlm.nih.gov/pubmed/28069011
http://dx.doi.org/10.1186/s12944-016-0388-z
_version_ 1782493140370849792
author Zhou, Boda
Zu, Lingyun
Chen, Yong
Zheng, Xilong
Wang, Yuhui
Pan, Bing
Dong, Min
Zhou, Enchen
Zhao, Mingming
Zhang, Youyi
Zheng, Lemin
Gao, Wei
author_facet Zhou, Boda
Zu, Lingyun
Chen, Yong
Zheng, Xilong
Wang, Yuhui
Pan, Bing
Dong, Min
Zhou, Enchen
Zhao, Mingming
Zhang, Youyi
Zheng, Lemin
Gao, Wei
author_sort Zhou, Boda
collection PubMed
description BACKGROUND: High density lipoprotein (HDL) has been proved to be a protective factor for coronary heart disease. Notably, HDL in atherosclerotic plaques can be nitrated (NO(2)-oxHDL) and chlorinated (Cl-oxHDL) by myeloperoxidase (MPO), likely compromising its cardiovascular protective effects. METHOD: Here we determined the effects of NO(2)-oxHDL and Cl-oxHDL on SMC migration using wound healing and transwell assays, proliferation using MTT and BrdU assays, and apoptosis using Annexin-V assay in vitro, as well as on atherosclerotic plaque stability in vivo using a coratid artery collar implantation mice model. RESULTS: Our results showed that native HDL promoted SMC proliferation and migration, whereas NO(2)-oxHDL and Cl-oxHDL inhibited SMC migration and reduced capacity of stimulating SMC proliferation as well as migration, respectively. OxHDL had no significant influence on SMC apoptosis. In addition, we found that ERK1/2-phosphorylation was significantly lower when SMCs were incubated with NO(2)-oxHDL and Cl-oxHDL. Furthermore, transwell experiments showed that differences between native HDL, NO(2)-oxHDL and Cl-oxHDL was abolished after PD98059 (MAPK kinase inhibitor) treatment. In aortic SMCs from scavenger receptor BI (SR-BI) deficient mice, differences between migration of native HDL, NO(2)-oxHDL and Cl-oxHDL treated SMCs vanished, indicating SR-BI’s possible role in HDL-associated SMC migration. Importantly, NO(2)-oxHDL and Cl-oxHDL induced neointima formation and reduced SMC positive staining cells in atherosclerotic plaque, resulting in elevated vulnerable index of atherosclerotic plaque. CONCLUSION: These findings implicate MPO-catalyzed oxidization of HDL may contribute to atherosclerotic plaque instability by inhibiting SMC proliferation and migration through MAPK-ERK pathway which was dependent on SR-BI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0388-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5223295
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-52232952017-01-11 Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration Zhou, Boda Zu, Lingyun Chen, Yong Zheng, Xilong Wang, Yuhui Pan, Bing Dong, Min Zhou, Enchen Zhao, Mingming Zhang, Youyi Zheng, Lemin Gao, Wei Lipids Health Dis Research BACKGROUND: High density lipoprotein (HDL) has been proved to be a protective factor for coronary heart disease. Notably, HDL in atherosclerotic plaques can be nitrated (NO(2)-oxHDL) and chlorinated (Cl-oxHDL) by myeloperoxidase (MPO), likely compromising its cardiovascular protective effects. METHOD: Here we determined the effects of NO(2)-oxHDL and Cl-oxHDL on SMC migration using wound healing and transwell assays, proliferation using MTT and BrdU assays, and apoptosis using Annexin-V assay in vitro, as well as on atherosclerotic plaque stability in vivo using a coratid artery collar implantation mice model. RESULTS: Our results showed that native HDL promoted SMC proliferation and migration, whereas NO(2)-oxHDL and Cl-oxHDL inhibited SMC migration and reduced capacity of stimulating SMC proliferation as well as migration, respectively. OxHDL had no significant influence on SMC apoptosis. In addition, we found that ERK1/2-phosphorylation was significantly lower when SMCs were incubated with NO(2)-oxHDL and Cl-oxHDL. Furthermore, transwell experiments showed that differences between native HDL, NO(2)-oxHDL and Cl-oxHDL was abolished after PD98059 (MAPK kinase inhibitor) treatment. In aortic SMCs from scavenger receptor BI (SR-BI) deficient mice, differences between migration of native HDL, NO(2)-oxHDL and Cl-oxHDL treated SMCs vanished, indicating SR-BI’s possible role in HDL-associated SMC migration. Importantly, NO(2)-oxHDL and Cl-oxHDL induced neointima formation and reduced SMC positive staining cells in atherosclerotic plaque, resulting in elevated vulnerable index of atherosclerotic plaque. CONCLUSION: These findings implicate MPO-catalyzed oxidization of HDL may contribute to atherosclerotic plaque instability by inhibiting SMC proliferation and migration through MAPK-ERK pathway which was dependent on SR-BI. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12944-016-0388-z) contains supplementary material, which is available to authorized users. BioMed Central 2017-01-10 /pmc/articles/PMC5223295/ /pubmed/28069011 http://dx.doi.org/10.1186/s12944-016-0388-z Text en © The Author(s). 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Zhou, Boda
Zu, Lingyun
Chen, Yong
Zheng, Xilong
Wang, Yuhui
Pan, Bing
Dong, Min
Zhou, Enchen
Zhao, Mingming
Zhang, Youyi
Zheng, Lemin
Gao, Wei
Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
title Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
title_full Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
title_fullStr Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
title_full_unstemmed Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
title_short Myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
title_sort myeloperoxidase-oxidized high density lipoprotein impairs atherosclerotic plaque stability by inhibiting smooth muscle cell migration
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223295/
https://www.ncbi.nlm.nih.gov/pubmed/28069011
http://dx.doi.org/10.1186/s12944-016-0388-z
work_keys_str_mv AT zhouboda myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT zulingyun myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT chenyong myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT zhengxilong myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT wangyuhui myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT panbing myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT dongmin myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT zhouenchen myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT zhaomingming myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT zhangyouyi myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT zhenglemin myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration
AT gaowei myeloperoxidaseoxidizedhighdensitylipoproteinimpairsatheroscleroticplaquestabilitybyinhibitingsmoothmusclecellmigration